콜레스테롤 산화생성물에 의해 유발된뇌 Synaptosome 기능이상에 미치는Tyrphostin AG126의 억제 효과

키워드

참고문헌 (40)

1. Bjorkhem I, "Oxysetrols and Alzheimer’s disease", Acta Neurol Scand Suppl, 185, pp.43~49 (2006)
2. Vaya J, "Oxysterols, cholesterol homeostasis, and Alzheimer disease", J Neurochem, 102, pp.1727~1737 (2007)
3. Olanow CW, "Etiology and pathogenesis of Parkinson’s disease", Annu Rev Neurosci, 22, pp.123~144 (1999)
4. Draczynska-Lusiak B, "Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer disease", Mol Chem Neuropathol, 33, pp.139~148 (1998)
5. Keller JN, "Oxidized low-density lipoprotein induces neuronal death: implications for calcium, reactive oxygen species, and caspases", J Neurochem, 72, pp.2601~2609 (1999)
6. Smith LL, "Sterol metabolism XLVII. Oxidized cholesterol esters in human tissues", J Steroid Biochem, 14, pp.889~900 (1981)
7. Ross R, "The pathogenesis of atherosclerosis: a perspective for the 1990s", Nature, 362, pp.801~809 (1993)
8. Nelson TJ, "Oxidation of cholesterol by amyloid precursor protein and β-amyloid peptide", J Biol Chem, 280, pp.7377~7387 (2005)
9. Sugawa M, "Oxidized low density lipoprotein caused CNS neuron cell death", Brain Res, 27, pp.165~172 (1997)
10. Berthier A, "Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis", Cell Death Differ, 11, pp.897~905 (2004)
11. Panini SR, "Arachidonate metabolism and the signaling pathway of induction of apoptosis by oxidized LDL", oxysterol, 2001, pp.42, 1678~1686
12. Nicholls DG, "Regulation of calcium in isolated nerve terminals (synaptosomes): relationship to neurotransmitter release", Ann N Y Acad Sci, 568, pp.81~88 (1989)
13. Sanchez-Prieto J, "Presynaptic receptors and the control of glutamate exocytosis", Trends Neurosci, 19, pp.235~239 (1996)
14. Atlante A, "Glutamate neurotoxicity, oxidative stress and mitochondria", FEBS Lett, 497, pp.1~5 (2001)
15. Dugan LL, "Excitotoxicity, free radicals, and cell membrane changes", Ann Neurol, 35, pp.17~21 (1994)
16. Sagara Y, "Tyrphostins protect neuronal cells from oxidative stress", J Biol Chem, 277, pp.36204~36215 (2002)
17. Kaul S, "Tyrosine phosphorylation regulates the proteolytic activation of protein kinase Cδ in dopaminergic neuronal cells", J Biol Chem, 280, pp.28721~28730 (2005)
18. Hou XY, "PP2, a potent inhibitor of Src family kinases, protects against hippocampal CA1 pyramidal cell death after transient global brain ischemia", Neurosci Lett, 420, pp.235~239 (2007)
19. Baldwin ML, "Src family tyrosine kinases differentially modulate exocytosis from rat brain nerve terminals", Neurochem Int, 49, pp.80~86 (2006)
20. Wang SJ, "A role for Src kinase in the regulation of glutamate release from rat cerebrocortical nerve terminals", Neuroreport, 14, pp.1519~1522 (2003)
21. Shyu KG, "PP2 inhibits glutamate release from nerve endings by affecting vesicle mobilization", Neuroreport, 16, pp.1969~1972 (2005)
22. Hanisch UK, "The protein tyrosine kinase inhibitor AG126 prevents the massive microglial cytokine induction by pneumococcal cell walls", Eur J Immunol, 31, pp.2104~2115 (2001)
23. Chatterjee PK, "The tyrosine kinase inhibitor tyrphostin AG126 reduces renal ischemia", reperfusion injury in the rat, 2003, pp.64, 1605~1619
24. Sihra TS, "Localized Ca2+ entry preferentially effects protein dephosphorylation, phosphorylation, and glutamate release", J Biol Chem, 167, pp.1983~1989 (1992)
25. Wang SJ, "Unexpected inhibitory regulation of glutamate release from rat cerebrocortical nerve terminals by presynaptic 5-hydroxytryptamine-2A receptors", J Neurosci Res, 84, pp.1528~1542 (2006)
26. Huttunen MT, "Measurements of membrane potentials in Escherichia coli K-12 inner membrane vesicles with the safranine method", Biochim Biophys Acta, 597, pp.274~284 (1980)
27. Horwitt BN, "Determination of inorganic serum phosphate by means of stannous chloride", J Biol Chem, 199, pp.537~541 (1952)
28. Silva VS, "Comparative effects of aluminum and ouabain on synaptosomal choline uptake, acetylcholine release and (Na+", K+) ATPase, 2007, pp.236, 158~177
29. Kristofikova Z, "Complex of Amyloid β peptides with 24-hydroxycholesterol and its effect on hemicholinium-3 sensitive carriers", Neurochem Res, 33, pp.412~421 (2008)
30. Jellinger KA, "The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson’s disease", Drugs Aging, 14, pp.115~140 (1999)
31. Vatassery GT, "Oxidation of cholesterol in synaptosomes and mitochondria isolated from rat brains", Lipids, 32, pp.879~886 (1997)
32. Miguet-Alfonsi C, "Analysis of oxidative processes and of myelin figures formation before and after the loss of the mitochondrial transmembrane potential during 7β-hydroxycholesterol and 7-ketocholesterol-induced apoptosis: comparison with various pro-apoptotic chemicals", Biochem Pharmacol, 64, pp.527~541 (2002)
33. Yang L, "25-Hydroxycholesterol activates a cytochrome c release-mediated caspase cascade", Biochem Biophys Res Commun, 278, pp.557~563 (2000)
34. Whittaker VP, "Thirty years of synaptosome research", J Neurocytol, 22, pp.735~742 (1993)
35. Tibbs GR, "Repetitive action potentials in isolated nerve terminals in the presence of 4-aminopyridine: effects on cytosolic free Ca2+ and glutamate release", J Neurochem, 53, pp.1693~1699 (1989)
36. Lee CS, "Differential modulation of 7-ketocholesterol toxicity against PC12 cells by calmodulin antagonists and Ca2+ channel blockers", Neurochem Res, 32, pp.87~98 (2007)
37. Adam-Vizi V, "Release of acetylcholine from rat brain synaptosomes by various agents in the absence of external calcium ions", J Physiol, 353, pp.505~521 (1984)
38. Stahl WL, "Na+,K+-ATPase: structure, function, and interactions with drugs", Adv Neurol, 44, pp.681~693 (1986)
39. Meyer EM, "Correlations between Na+-K+ ATPase activity and acetylcholine release in rat cortical synaptosomes", J Neurochem, 36, pp.467~475 (1981)
40. Marzocco S, "Tyrphostin AG 126 reduces intestinal ischemia-reperfusion injury in the rat", Naunyn Schmiedebergs Arch Pharmacol, 372, pp.362~373 (2006)